Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BIMI delisted from the Nasdaq to the OTC:
https://otce.finra.org/otce/dailyList?viewType=Additions
FROM 0.32 TO 0.65 = 100%+ ... :)))))))))))))))))))))))))))))))))))))))
BIMI
BIMI.................................https://stockcharts.com/h-sc/ui?s=BIMI&p=W&b=5&g=0&id=p86431144783
Double Bottom on the daily. 930k float. Short interest below 1%.
Not worried about the delinquency notice. This will run hard on any news.
$1.05 - $1.12 range I'm adding heavy.
Soooo no post since last year? Looks pretty promising here in next few months…. Strong buy signals…
Bimi International Medical Inc NASDAQ: BIMI
GoSymbol lookup
Health Care : Health Care Providers & Services | Small Cap ValueCompany profile
BIMI International Medical Inc. is a holding company. The Company, through its subsidiaries, is building a comprehensive healthcare ecosystem, centered on online and offline healthcare products and services, including retail and wholesale sales of medical devices and pharmaceuticals, and hospital services. Its wholesale medical devices segment distributes medical devices, including medical consumables to drug stores, private clinics, pharmaceutical dealers and hospitals. Its wholesale pharmaceuticals segment is engaged in supplying prescription and over-the-counter (OTC) medicines, traditional Chinese medicines (TCM), healthcare supplies and sundry items to clinics, third party pharmacies, hospitals and other drug vendors. The medical services segment includes the hospitals business. The retail pharmacy segment sells prescription and OTC medicines, TCM, healthcare supplies, and sundry items to retail customers through its directly owned pharmacies and authorized retail stores.
Almost $600,000 day went unnoticed the other day.
its moving up fast last couple of …
…
mins here, and into a/h.
He might be owning a lot more than that but I know he doesn't care..lol
lol$BIMI I keep adding I don’t mind owning 4.99% of the public float
— Zack Morris (@MrZackMorris) August 23, 2022
grabbed a few here, hi cj!
Oh I know he can you just want to be in before the dump comes...
+13%
ZM is going to have to buy more..
Lol do they even have money to purchase?? Imo??
What do you think about the price target?
Ayyyyye back at 0% gains for the day. At least no losses lol...
Well than, the current price is the equivalent of .28... compared to yesterday's highs in the .40s meaning it's almost down 50% from yesterday morning
Yep...looks like 1.63 at the bell tomorrow.
With r/s of 1.5, they are barely trading over $ 1,-. That's not good....
Reverse Split tonight at 5pm EST. Divide your shares by 5.
NEW YORK, Feb. 02, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced a 1-for-5 reverse split of its common stock effective today at 5:00 PM EST. Beginning on February 3, 2022, the Company’s common stock will trade on Nasdaq on a split adjusted basis.
Price target 12.50 https://money.cnn.com/quote/forecast/forecast.html?symb=BIMI
NEWS: BIMI International Medical Inc. Signs Stock Purchase Agreement With Bengbu Mali OB-GYN Hospital December 21 2021 - 08:30AM
BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”) today announced that it has signed a stock purchase agreement with Bengbu Mali OB-GYN Hospital (the “Mali Hospital”), also known as Bengbu Mali Maternity Hospital.
The aggregate purchase price (the “Purchase Price”) for the Mali Hospital is US$16,750,000. The consideration consists of cash in the amount of US$2,800,000 and 3,000,000 newly-issued shares of common stock of BIMI (the “Parent Shares”), with an agreed upon value by the parties of US$9,000,000 at US$3.00 per share, is to be paid at the Closing.
The remainder of the purchase price of 1,650,000 shares of Common Stock valued at US$4,950,000, or $3.00 per share (the “Earnout Amount”), is subject to post-closing adjustments based on the performance of Mali Hospital in 2022 and 2023. If the net profit of Mali Hospital in 2022 equals or exceeds the net profit target, which is approximately US $770,000 (RMB 5,000,000), approximately 50% of the Earnout Amount will be paid to the sellers or their designees by the issuance of 800,000 shares of Common Stock. If the net profit target is not met, a reduced number of shares of Common Stock will be issuable based on the ratio of the actual net profit to the net profit target. The sellers or their designees will receive about 50% (or a smaller portion) of the Earnout Amount (850,000 shares of Common Stock), subject to Mali Hospital reaching a similar performance target in 2023.
“The acquisition of the Mali Hospital enhances our hospital chain for obstetrics and gynecology. We plan to shortly open new departments in this hospital, including minimally invasive plastic surgery, Ophthalmology and Rehabilitation. We predict these new departments could account for 45% of hospital’s revenue in two years,” said Mr. Tiewei Song, Chief Executive Officer and President of BIMI International Medical Inc.
About BIMI International Medical Inc.
BIMI International Medical Inc. was founded in 2006. The Company is now exclusively a healthcare products and provider, offering a broad range of healthcare products and related services and operates five private hospitals in China. For more information, please visit www.usbimi.com.
Safe Harbor Statement
Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to, the Company’s ability to achieve profitable operations, its ability to continue to operate as a going concern, its ability to continue to meet NASDAQ continued listing requirements, the effects of the spread of COVID-19, the demand for the Company’s products and services in the People’s Republic of China, general economic conditions and other risk factors detailed in the Company’s annual report and other filings with the United States Securities and Exchange Commission.
IR Contact:
Dragon Gate Investment Partners LLC
Tel: +1(646)-801-2803
Email: BIMI@dgipl.com
3 cent spread between bid and ask price! Let’s keep it thin and far in between so we can soar!
Weak hands are leaving in this consolidation zone
Sold half at $1.14.....holding rest for a rant day. TY BIMI. Had to take some off. Back to bed